Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE-iVAC: Everolimus vs MMF/MPA for Vaccine Response in Kidney Transplant
NCT05924685Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplantation, sponsored by University Medical Center Groningen. Started Aug 2023; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT05924685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924685.